CRBU vs. QS

In the year-to-date period, CRBU achieves a -68.59% return, which is significantly lower than QS's -27.77% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Caribou Biosciences, Inc. (CRBU) and QuantumScape Corporation (QS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current CRBU Sharpe Ratio is -0.80, which is lower than the QS Sharpe Ratio of -0.35. The chart below compares the historical Sharpe Ratios of CRBU and QS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither CRBU nor QS has paid dividends to shareholders.

The maximum CRBU drawdown since its inception was -94.85%, roughly equal to the maximum QS drawdown of -96.41%. Use the drawdown chart below to compare losses from any high point for CRBU and QS. For additional features, visit the drawdowns tool.

Caribou Biosciences, Inc. (CRBU) has a higher volatility of 21.84% compared to QuantumScape Corporation (QS) at 16.28%. This indicates that CRBU's price experiences larger fluctuations and is considered to be riskier than QS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Caribou Biosciences, Inc. and QuantumScape Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.